Second Regular Session | 74th General Assembly
Colorado General AssemblyPresented to the Opioid and Other Substance Use Disorders Interim Study Committee at its September 2017 meeting.
This Fact Sheet provides detailed information on the Colorado Correctional Industries (CCi), a self-supporting division of the Department of Corrections (DOC), which oversees and manages prison work programs in the state. Established in 1977, CCi’s purpose, as defined in state law, includes...
Final Report to the Colorado General Assembly by the County Courthouse and County Jail Funding and Overcrowding Solutions Interim Study Committee.
Final Report to the Colorado General Assembly by the Opioid and Other Substance Use Disorders Interim Study Committee.
During the 2017 legislative session, the General Assembly considered measures related to Colorado’s behavioral health crisis system and the use and misuse of opioids. Other issues considered include child care regulations, child welfare, and a job program for individuals receiving cash...
This memo compares Colorado’s felony sentencing laws with those of Minnesota, Nebraska, New Mexico, Oregon, and Washington. It provides an overview of determinate versus indeterminate sentencing schemes and incarceration rates.
This memo explains enhanced sentencing requirements for two different criminal offense categories: crimes of violence and habitual offenders. It also provides sentencing data for offenders convicted of crimes of violence or as habitual offenders between 2014 and 2016. During this three year...
This memorandum provides information concerning second look sentencing. Second look sentencing refers to sentence modification that occurs while an offender is serving his or her term of incarceration. This memorandum briefly describes second look sentencing and discusses the differences...
This memorandum provides an overview of the mandatory minimum sentencing schemes in Colorado law. It provides information on the general categories of offenses subject to enhanced prison sentences and specific crimes that require a mandatory minimum sentence. Three years of sentencing data are...
Presented to the TLRC at its November 2, 2017 meeting.
This memorandum addresses patient access to experimental treatments, including access to clinical trials, participation in the U.S. Food and Drug Administration’s Expanded Access (Compassionate Use) Program, and access to treatments under Colorado’s Right to Try Act. Additionally, this...